Cellular Signaling in Health and Disease

Nonfiction, Science & Nature, Science, Biological Sciences, Biophysics, Health & Well Being, Medical, Medical Science, Physiology
Cover of the book Cellular Signaling in Health and Disease by Martin Beckerman, Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Martin Beckerman ISBN: 9780387981734
Publisher: Springer New York Publication: May 28, 2009
Imprint: Springer Language: English
Author: Martin Beckerman
ISBN: 9780387981734
Publisher: Springer New York
Publication: May 28, 2009
Imprint: Springer
Language: English

In today’s world, three great classes of non-infectious diseases – the metabolic syndromes (such as type 2 diabetes and atherosclerosis), the cancers, and the neurodegenerative disorders – have risen to the fore. These diseases, all associated with increasing age of an individual, have proven to be remarkably complex and difficult to treat. This is because, in large measure, when the cellular signaling pathways responsible for maintaining homeostasis and health of the body become dysregulated, they generate equally stable disease states. As a result the body may respond positively to a drug, but only for a while and then revert back to the disease state. Cellular Signaling in Health and Disease summarizes our current understanding of these regulatory networks in the healthy and diseased states, showing which molecular components might be prime targets for drug interventions. This is accomplished by presenting models that explain in mechanistic, molecular detail how a particular part of the cellular signaling web operates properly in health and improperly in disease.

The stability of the health- and disease-associated states is dynamic and supported by multiple feedback loops acting positively and negatively along with linkages between pathways. During the past few years an ongoing series of important discoveries have been made that advance our understanding of how the body works and may guide us on how to better deal with these diseases. These include the discovery of chronic inflammation as a causal factor in all of these disease classes, the appearance of reactive oxygen species as a messenger molecule that can act both positively and negatively, the propensity of proteins to misfold into aggregation- and disease-prone forms, and the rise of epigenetics including the emergence of small non-coding RNA with important regulatory functions out of the so-called junk RNA. Chapters are devoted to each of these classes of findings with additional details integrated into the chapters dealing directly with the diseases. The connections responsible for maintaining stability are explored in depth.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In today’s world, three great classes of non-infectious diseases – the metabolic syndromes (such as type 2 diabetes and atherosclerosis), the cancers, and the neurodegenerative disorders – have risen to the fore. These diseases, all associated with increasing age of an individual, have proven to be remarkably complex and difficult to treat. This is because, in large measure, when the cellular signaling pathways responsible for maintaining homeostasis and health of the body become dysregulated, they generate equally stable disease states. As a result the body may respond positively to a drug, but only for a while and then revert back to the disease state. Cellular Signaling in Health and Disease summarizes our current understanding of these regulatory networks in the healthy and diseased states, showing which molecular components might be prime targets for drug interventions. This is accomplished by presenting models that explain in mechanistic, molecular detail how a particular part of the cellular signaling web operates properly in health and improperly in disease.

The stability of the health- and disease-associated states is dynamic and supported by multiple feedback loops acting positively and negatively along with linkages between pathways. During the past few years an ongoing series of important discoveries have been made that advance our understanding of how the body works and may guide us on how to better deal with these diseases. These include the discovery of chronic inflammation as a causal factor in all of these disease classes, the appearance of reactive oxygen species as a messenger molecule that can act both positively and negatively, the propensity of proteins to misfold into aggregation- and disease-prone forms, and the rise of epigenetics including the emergence of small non-coding RNA with important regulatory functions out of the so-called junk RNA. Chapters are devoted to each of these classes of findings with additional details integrated into the chapters dealing directly with the diseases. The connections responsible for maintaining stability are explored in depth.

More books from Springer New York

Cover of the book Peeking at Peak Oil by Martin Beckerman
Cover of the book When Doctors Kill by Martin Beckerman
Cover of the book Distributed Hash Table by Martin Beckerman
Cover of the book The Art of Software Thermal Management for Embedded Systems by Martin Beckerman
Cover of the book Principles of Research Methodology by Martin Beckerman
Cover of the book Partial Differential Equations by Martin Beckerman
Cover of the book Stress-Induced Mutagenesis by Martin Beckerman
Cover of the book The Archaeology of Maritime Landscapes by Martin Beckerman
Cover of the book The Circadian Clock by Martin Beckerman
Cover of the book Modeling Tumor Vasculature by Martin Beckerman
Cover of the book Nanotechnology for Biology and Medicine by Martin Beckerman
Cover of the book Chemical and Bioprocess Engineering by Martin Beckerman
Cover of the book Video Image Detection Systems Installation Performance Criteria by Martin Beckerman
Cover of the book Physiological Mechanisms and Adaptation Strategies in Plants Under Changing Environment by Martin Beckerman
Cover of the book Ayurvedic Science of Food and Nutrition by Martin Beckerman
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy